...
首页> 外文期刊>Clinical and experimental hypertension: CEH >Plasma plasminogen activator inhibitor 1 (PAI-1) and P-selectin levels in urgent hypertension: effect of single dose captopril and nifedipine on fibrinolytic activity.
【24h】

Plasma plasminogen activator inhibitor 1 (PAI-1) and P-selectin levels in urgent hypertension: effect of single dose captopril and nifedipine on fibrinolytic activity.

机译:紧急高血压中的血浆纤溶酶原激活物抑制剂1(PAI-1)和P-选择素水平:单剂量卡托普利和硝苯地平对纤溶活性的影响。

获取原文
获取原文并翻译 | 示例

摘要

In this study, we primarily aimed to identify the acute effects of hypertension on fibrinolytic function in previously untreated urgent hypertensive patients and to evaluate the influence of two commonly used, short-acting, anti-hypertensive agents, captopril and nifedipine, in these patients. Patient groups were selected homogeneously, i.e., only previously untreated patients amidst an urgent hypertensive episode and having no co-morbid disease were included-and randomly assigned to receive either captopril or nifedipine for immediate management. These two treatment groups were matched for age, gender, and mean arterial blood pressure. Study results demonstrated that lowering blood pressure with either agent improved fibrinolytic function; however, in those patients given captopril, this beneficial effect was more prominent, providing evidence supporting the preferential use of short-acting, angiotensin-converting enzyme (ACE) inhibitors in this setting.
机译:在这项研究中,我们主要旨在确定高血压对先前未治疗的紧急高血压患者的纤溶功能的急性影响,并评估这些患者中两种常用的短效抗高血压药卡托普利和硝苯地平的影响。均等地选择患者组,即,仅包括先前在紧急高血压发作中且没有合并症的未接受治疗的患者,并随机分配接受卡托普利或硝苯地平治疗。这两个治疗组的年龄,性别和平均动脉血压相匹配。研究结果表明,两种药物均能降低血压,改善纤溶功能。然而,在接受卡托普利治疗的患者中,这种有益作用更为显着,提供了支持在这种情况下优先使用短效血管紧张素转换酶(ACE)抑制剂的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号